TransCode Therapeutics, Inc. (RNAZ)
9.69
-0.69
(-6.65%)
USD |
NASDAQ |
Feb 20, 16:00
9.09
-0.60
(-6.19%)
After-Hours: 20:00
TransCode Therapeutics EPS Diluted (Quarterly) : -5.825 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| ACADIA Pharmaceuticals, Inc. | 0.4206 |
| Alnylam Pharmaceuticals, Inc. | 1.368 |
| Savara, Inc. | -0.1366 |
| BioMarin Pharmaceutical, Inc. | -0.1601 |
| Imunon, Inc. | -1.165 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -4.856M |
| Total Expenses (Quarterly) | 4.856M |
| Enterprise Value | 5.242M |
| Earnings Yield | -2.50K% |
| Normalized Earnings Yield | -1922.60 |